CC
SRPT icon

Corsicana & Co’s Sarepta Therapeutics SRPT Stock Holding History

Corsicana & Co’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$11K Hold
100
– – 0.01% 170
2022
Q2 		$7K Hold
100
– – 0.01% 186
2022
Q1 		$8K Sell
100
-300
-75% -$23K 0.01% 185
2021
Q4 		$36K Hold
400
– – 0.02% 149
2021
Q3 		$37K Hold
400
– – 0.02% 144
2021
Q2 		$31K Buy
+400
New +$30.3K 0.02% 146

Other funds holding SRPT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Corsicana & Co's SRPT Position: Q3 2022 in Review

Corsicana & Co held its Sarepta Therapeutics (SRPT) position steady in Q3 2022 at 100 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #170.

Corsicana & Co first reported a position in SRPT in Q2 2021 and has held it in 6 quarters since. The position peaked at $37K in Q3 2021. 375 funds tracked by Wall St. Rank hold SRPT as of Q3 2022.

  • Corsicana & Co held 100 shares of Sarepta Therapeutics worth $11K as of Q3 2022.
  • Corsicana & Co left its Sarepta Therapeutics share count unchanged in Q3 2022.
  • Sarepta Therapeutics made up 0.01% of Corsicana & Co's portfolio in Q3 2022, its #170 holding.
  • Corsicana & Co first reported a position in Sarepta Therapeutics in Q2 2021 and has held it in 6 quarters since.
  • Corsicana & Co's Sarepta Therapeutics position peaked at $37K in Q3 2021.
  • 375 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2022.

Based on Corsicana & Co's 13F filing for Q3 2022, filed 14 Oct 2022.